Legislation & Regulation
John Carroll
Health plans can expect to pay less in dues, but whether the new organization will have increased influence with legislators remains to be seen.
Michael S. Victoroff, MD
A program to reduce medical errors promised providers that confidentiality would be protected. Then came a problem demanding immediate attention.
Tomorrow's Medicine
Thomas Morrow, MD
Treatments that interfere with protein synthesis at the cellular level will soon be debated in medical policy committee meetings.

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report